Welch & Forbes LLC’s Resmed Inc Position
Does Welch & Forbes LLC own Resmed Inc (RME)? Yes — 326.4K shares worth $73M (+0.95% of its 13F portfolio) as of Q1 2026, down from 328.4K shares the prior filed quarter.
Position Value
$73M
Q1 2026
Shares
326.4K
% of Portfolio
+0.95%
Quarters Held
30
currently held
Position History RME
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 326.4K | $73M | +0.95% |
| Q4 2025 | 328.4K | $79M | +0.96% |
| Q3 2025 | 329.8K | $90M | +1.09% |
| Q2 2025 | 331.6K | $86M | +1.07% |
| Q1 2025 | 329.9K | $74M | +0.97% |
| Q4 2024 | 327.8K | $75M | +0.96% |
| Q3 2024 | 327.0K | $80M | +1.02% |
| Q2 2024 | 325.4K | $62M | +0.83% |
| Q1 2024 | 323.0K | $64M | +0.88% |
| Q4 2023 | 310.5K | $53M | +0.81% |
| Q3 2023 | 317.4K | $47M | +0.78% |
| Q2 2023 | 308.2K | $67M | +1.06% |
| Q1 2023 | 305.5K | $67M | +1.13% |
| Q4 2022 | 306.3K | $64M | +1.14% |
| Q3 2022 | 312.4K | $68M | +1.33% |
| Q2 2022 | 314.4K | $66M | +1.21% |
| Q1 2022 | 313.8K | $76M | +1.20% |
| Q4 2021 | 311.4K | $81M | +1.21% |
| Q3 2021 | 311.2K | $82M | +1.36% |
| Q2 2021 | 312.0K | $77M | +1.30% |
| Q1 2021 | 310.7K | $60M | +1.11% |
| Q4 2020 | 303.0K | $64M | +1.26% |
| Q3 2020 | 306.3K | $53M | +1.13% |
| Q2 2020 | 293.3K | $56M | +1.32% |
| Q1 2020 | 295.4K | $44M | +1.22% |
| Q4 2019 | 299.4K | $46M | +1.03% |
| Q3 2019 | 301.7K | $41M | +0.97% |
| Q2 2019 | 302.6K | $37M | +0.90% |
| Q1 2019 | 304.2K | $32M | +0.79% |
| Q4 2018 | 302.5K | $34M | +0.97% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Welch & Forbes LLC’s full portfolio or all institutional holders of RME.